Abstract
The temporary use of the bioenterics intragastric balloon in morbid obesity is increasing worldwide. Generally, this is an effective procedure that helps bring about satisfactory weight loss and improvement in comorbidities after 6 months. However, in some cases, it causes complications such as acute abdomen due to gastric perforation and even death. We describe the case of a type II obese female (weight, 88 kg; body mass index, 35.2 kg/m2) who underwent emergency surgery for gastric necrosis caused by bioenterics intragastric balloon; the patient required total gastrectomy and intensive care.
This is a preview of subscription content, log in via an institution to check access.
References
Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obes Surg. 2003;13:329–30.
World Health Organization. World health report 2006. Available at: https://doi.org/www.iotf.org. Accessed Nov 2008.
Escudero A, Catalán I, Gonzalvo J, et al. Effectiveness, safety, and tolerability of intragastric balloon in association with low-calorie diet for the treatment of obese patients. Rev Esp Enferm Dig. 2008;100:349–54.
Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1:198–9.
Bioenterics intragastric balloon system, catalog. Available at: https://doi.org/www.bioenterics.com. Accessed Nov 2008.
Genco A, Bruni T, Doldi SB, et al. Bioenterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Rodríguez-Hermosa JI, Ruiz-Feliú, Roig-García J, et al. Lethal intestinal perforation after foreign body ingestion in a superobese patient. Obes Surg 2009 (in press).
Nijhof HW, Steenvoorde P, Tollenaar RA. Perforation of the esophagus caused by the insertion of an intragastric balloon for the treatment of obesity. Obes Surg. 2006;16:667–70.
Juchems MJ, Uyak D, Ernst AS, et al. Monitoring gastric filling, satiety and gastric emptying in a patient with gastric balloon using functional magnetic resonance imaging–a feasibility report. Clinical Medicine: Case Reports. 2008;1:41–4.
Roman S, Napoléon B, Mion F, et al. Intragastric balloon for “non-morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.
De Peppo F, Di Giorgio G, Germani M, et al. Bioenterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg. 2008;18:1443–9.
Totté E, Hendrickx L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the bioenterics intragastric balloon. Obes Surg. 2001;11:519–23.
Rodríguez-Hermosa JI, Roig J, Sirvent JM, et al. Gastric perforations from abdominal trauma. Dig Surg. 2008;25:109–16.
Rodríguez-Hermosa JI, Codina-Cazador A, Sirvent JM, et al. Surgically treated perforations of the gastrointestinal tract caused by ingested foreign bodies. Colorectal Dis. 2008;10:701–7.
Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high-risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.
Dumonceau JM. Evidence-based review of the bioenterics intragastric balloon for weight loss. Obes Surg 2008;18:1611–7.
Ganesh R, Rao AD, Baladas HG, et al. The bioenterics intragastric balloon (BIB) as a treatment for obesity: poor results in Asian patients. Singapore Med J. 2007;48:227–31.
Imaz I, Martínez-Cervell C, García-Álvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodríguez-Hermosa, J.I., Roig-García, J., Gironès-Vilà, J. et al. Gastric Necrosis: A Possible Complication of the Use of the Intragastric Balloon in a Patient Previously Submitted to Nissen Fundoplication. OBES SURG 19, 1456–1459 (2009). https://doi.org/10.1007/s11695-009-9855-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-009-9855-1